AESKU.GROUP
Rodrigo Berlie currently serves as Chief Operating Officer at AESKU.GROUP since May 2023, focusing on overseeing daily operations and strategic functions while driving business transformation across all legal entities. Prior experience includes roles at Gold Standard Diagnostics Europe as Senior Director of Commercial Operations, where Rodrigo was responsible for significant revenue generation and organizational transformation in response to COVID-19, achieving net sales of approximately 130 million euros in 2021 alone. Additional roles include Managing Director at Gold Standard Diagnostics Europe, where responsibilities encompassed all commercial operations, and VP of Commercial Operations at NovaTec Immundiagnostica GmbH, managing net sales of around 10 million euros. Early career experience includes serving as Director of Sales & Marketing at Syntron Bioresearch Inc. Rodrigo holds an MBA in Marketing from San Diego State University and a Bachelor's degree in Communication from the University of Brasilia.
This person is not in any teams
This person is not in any offices
AESKU.GROUP
We are a research-oriented provider of innovative, efficient products and services for early detection, diagnosis and prognosis of autoimmune and infectious diseases, allergies and food intolerances. We strive to improve the diagnosis and management of different diseases as a provider of innovative in-vitro diagnostic products that really work. Built on a tradition of innovation and an interdisciplinary knowledge network, AESKU.DIAGNOSTICS offers unique diagnostic options: faster, more efficient and reliable test systems designed to improve clinical outcomes for the benefit of patients and physicians. Follow us on our other Social Media Profiles. https://www.linkedin.com/company/dst-diagnostische-systeme-&-technologien-gmbh/about/ instagram: https://www.instagram.com/aesku.group/ Contact us: Website: www.aesku.com E-Mail: socialmedia@aesku.com